We’re back at Bventure! Cancerappy is actively participating in this innovation event through the University of Deusto, joining the roundtable discussion, “The Value of Talent in an AI Startup.” On Tuesday, Oct 15th, our CEO will share insights on how AI is impacting our work and driving progress in our field. Don’t miss it!
We are glad to announce that Luis Martin, the Chief Executive Officer of CancerAppy, will be presenting at the ACCESS CHINA Partnering Forum – Autumn Virtual Showcase during September 24th to 25th, and 27th, 2024. ACCESS CHINA Biotech Forum is the largest corporate access event between Asia and the western biopharma industry.
We’re excited to be part of BioSpain 2023, and despite our packed schedule, we welcome you to connect with us at the BasqueHealthCluster booth. Explore our groundbreaking work in the world of biotechnology and cancer research. See you there!.
Cancerappy participated in the II international congress organized by ATG Symbio Spain that was held in
Barcelona at the Biomedical Research Park (PRBB) on July 1 and 2, 2023.
Our CEO had the opportunity to present our company and show our latest advances in the NMEs that we are developing.
Our CEO will be attending the BIO International in Boston from June 5th to 8th.
Cancerappy is dedicated to the discovery and development of new AI-based pharmaceuticals. Currently, we have a strong pipeline that validates and demonstrates our value proposition.
If you want to learn more about Cancerappy, feel free to find us at booth 7 in the Spain Pavilion.
More about Bio Convention:
https://www.bio.org/events/bio-international-convention
From 15th to 18th of May, our CEO and CMO will be attending various international events in Hong Kong introducing the latest advances of our company. They will attend Asia Summit on Global Health, Invest in Honk Kong #investHK, and different meeting with local business Angels.